Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT00391989
What this trial is testing

Treatment of Adult Ph+ LAL With BMS-354825

Who this might be right for
Lymphoblastic Leukemia, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Testing effectiveness (Phase 2)Study completedNCT01643668
What this trial is testing

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT06679582
What this trial is testing

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Sutro Biopharma, Inc. 24
Not applicableStudy completedNCT01767558
What this trial is testing

PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)

Who this might be right for
Atrial Fibrillation
Medtronic Cardiac Rhythm and Heart Failure 56
Testing effectiveness (Phase 2)Looking for participantsNCT07471789
What this trial is testing

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Who this might be right for
Acute Myeloblastic LeukaemiaLeukemia, T-Cell
Gyala Therapeutics 33
Testing effectiveness (Phase 2)WithdrawnNCT03187691
What this trial is testing

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Matinas BioPharma Nanotechnologies, Inc.
Early research (Phase 1)Ended earlyNCT03360006
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 30
Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Looking for participantsNCT00501826
What this trial is testing

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 160
Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766850
What this trial is testing

Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
R/R AML
Christer C Nilsson 26
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Large-scale testing (Phase 3)Looking for participantsNCT05586074
What this trial is testing

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Who this might be right for
Leukemia, Acute Myeloid (AML)
Sunshine Lake Pharma Co., Ltd. 324
Testing effectiveness (Phase 2)Study completedNCT01957774
What this trial is testing

THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA

Who this might be right for
Stroke, Acute
D-Pharm Ltd. 30
Early research (Phase 1)Study completedNCT01397799
What this trial is testing

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
Kinex Pharmaceuticals Inc. 24
Large-scale testing (Phase 3)Ended earlyNCT00557921
What this trial is testing

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Cogentus Pharmaceuticals 5,000
Large-scale testing (Phase 3)Ended earlyNCT00338585
What this trial is testing

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Next Page